OTCMKTS:SEOVF Sernova Biotherapeutics Q2 2025 Earnings Report $0.06 +0.00 (+3.06%) As of 03:54 PM Eastern ProfileEarnings History Sernova Biotherapeutics EPS ResultsActual EPS-$0.01Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ASernova Biotherapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ASernova Biotherapeutics Announcement DetailsQuarterQ2 2025Date6/13/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Sernova Biotherapeutics Earnings HeadlinesSernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity ConferenceSeptember 25 at 7:00 AM | globenewswire.comSernova Biotherapeutics Inc SEOVFMay 14, 2026 | morningstar.comMSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.September 25 at 1:00 AM | Altimetry (Ad)Sernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to ...March 4, 2026 | finanznachrichten.deSernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical EffortsNovember 13, 2025 | finance.yahoo.comSernova Biotherapeutics Announces Collaboration with Eledon ...July 11, 2025 | morningstar.comMSee More Sernova Biotherapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sernova Biotherapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sernova Biotherapeutics and other key companies, straight to your email. Email Address About Sernova BiotherapeuticsSernova Biotherapeutics (OTCMKTS:SEOVF) is a clinical-stage biotechnology company focused on developing regenerative medicine technologies for the treatment of chronic diseases. Its platform combines an implantable device, therapeutic cells and methods intended to protect transplanted cells from immune-system rejection. The company’s primary technology is the Cell Pouch System, an implantable, vascularized device designed to house therapeutic cells and support their long-term function in the body. Sernova has investigated the platform for conditions including type 1 diabetes and hemophilia, with research involving insulin-producing islet cells and other cell-based therapies. Sernova is based in London, Ontario, Canada, and has conducted research and clinical development activities in collaboration with academic and medical institutions. The company has been led by Philip Toleikis, who serves as president and chief executive officer. Its programs remain focused on advancing cell-based treatments toward potential clinical use.View Sernova Biotherapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura Deal Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
